Non-pancreatic hyperlipasemia: A puzzling clinical entity

Table 5 Serum lipase and amylase levels according to the presence of complications in patients with non-pancreatic hyperlipasemia (n = 401)

	No. of patients	Lipase (U/L)		Amylase (U/L)
		Median	IQR	Median	IQR
No complications	239	264	229-428	159	106-226
Sepsis at all	111	425	263-651	216	112-343
AKI at all	133	398	259-625	190	99-335
AKI or sepsis	80	282	242-527	209	125-353
Sepsis and AKI	82	447	275-667	220	128-344
		P value		P value
None/sepsis at all		< 0.001		< 0.001
None/AKI at all		< 0.001		0.003
None/one (AKI or sepsis)		0.042		0.009
None/both (sepsis and AKI)		< 0.001		0.001

AKI: Acute kidney injury; AP: Acute pancreatitis; NPHL: Non-pancreatic hyperlipasemia; IQR: Interquartile range.